nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.623	1	CbGbCtD
Sumatriptan—Motor dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0143	0.0533	CcSEcCtD
Sumatriptan—Personality change—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0403	CcSEcCtD
Sumatriptan—Subarachnoid haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00953	0.0354	CcSEcCtD
Sumatriptan—HTR3A—cranial nerve—amyotrophic lateral sclerosis	0.00939	0.106	CbGeAlD
Sumatriptan—Hypoaesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.00797	0.0296	CcSEcCtD
Sumatriptan—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.00787	0.089	CbGeAlD
Sumatriptan—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.00762	0.0862	CbGeAlD
Sumatriptan—Salivary gland enlargement—Riluzole—amyotrophic lateral sclerosis	0.0075	0.0278	CcSEcCtD
Sumatriptan—Facial paralysis—Riluzole—amyotrophic lateral sclerosis	0.00654	0.0243	CcSEcCtD
Sumatriptan—Tetany—Riluzole—amyotrophic lateral sclerosis	0.00638	0.0237	CcSEcCtD
Sumatriptan—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.00583	0.0216	CcSEcCtD
Sumatriptan—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.00547	0.0203	CcSEcCtD
Sumatriptan—Yawning—Riluzole—amyotrophic lateral sclerosis	0.00517	0.0192	CcSEcCtD
Sumatriptan—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.00507	0.0188	CcSEcCtD
Sumatriptan—HTR3A—nerve—amyotrophic lateral sclerosis	0.00481	0.0544	CbGeAlD
Sumatriptan—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00431	0.016	CcSEcCtD
Sumatriptan—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00354	0.0131	CcSEcCtD
Sumatriptan—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00318	0.0118	CcSEcCtD
Sumatriptan—Cyst—Riluzole—amyotrophic lateral sclerosis	0.00311	0.0116	CcSEcCtD
Sumatriptan—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00305	0.0113	CcSEcCtD
Sumatriptan—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00305	0.0113	CcSEcCtD
Sumatriptan—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00299	0.0111	CcSEcCtD
Sumatriptan—MAOA—nerve—amyotrophic lateral sclerosis	0.00298	0.0336	CbGeAlD
Sumatriptan—DRD2—nerve—amyotrophic lateral sclerosis	0.00294	0.0333	CbGeAlD
Sumatriptan—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00294	0.0109	CcSEcCtD
Sumatriptan—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00294	0.0109	CcSEcCtD
Sumatriptan—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00291	0.0108	CcSEcCtD
Sumatriptan—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00291	0.0108	CcSEcCtD
Sumatriptan—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00289	0.0107	CcSEcCtD
Sumatriptan—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00276	0.0103	CcSEcCtD
Sumatriptan—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00272	0.0101	CcSEcCtD
Sumatriptan—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00962	CcSEcCtD
Sumatriptan—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00962	CcSEcCtD
Sumatriptan—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00244	0.0276	CbGeAlD
Sumatriptan—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00862	CcSEcCtD
Sumatriptan—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00856	CcSEcCtD
Sumatriptan—MAOA—hindbrain—amyotrophic lateral sclerosis	0.00223	0.0252	CbGeAlD
Sumatriptan—HTR1F—nervous system—amyotrophic lateral sclerosis	0.00222	0.025	CbGeAlD
Sumatriptan—DRD2—hindbrain—amyotrophic lateral sclerosis	0.0022	0.0249	CbGeAlD
Sumatriptan—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00817	CcSEcCtD
Sumatriptan—HTR1F—central nervous system—amyotrophic lateral sclerosis	0.00213	0.0241	CbGeAlD
Sumatriptan—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00792	CcSEcCtD
Sumatriptan—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00787	CcSEcCtD
Sumatriptan—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00782	CcSEcCtD
Sumatriptan—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00773	CcSEcCtD
Sumatriptan—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00773	CcSEcCtD
Sumatriptan—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00773	CcSEcCtD
Sumatriptan—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00768	CcSEcCtD
Sumatriptan—HTR3A—brainstem—amyotrophic lateral sclerosis	0.00206	0.0233	CbGeAlD
Sumatriptan—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00764	CcSEcCtD
Sumatriptan—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00755	CcSEcCtD
Sumatriptan—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00734	CcSEcCtD
Sumatriptan—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00726	CcSEcCtD
Sumatriptan—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00664	CcSEcCtD
Sumatriptan—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00658	CcSEcCtD
Sumatriptan—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00658	CcSEcCtD
Sumatriptan—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00651	CcSEcCtD
Sumatriptan—HTR1B—brainstem—amyotrophic lateral sclerosis	0.00173	0.0196	CbGeAlD
Sumatriptan—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00639	CcSEcCtD
Sumatriptan—HTR1F—brain—amyotrophic lateral sclerosis	0.00169	0.0191	CbGeAlD
Sumatriptan—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00627	CcSEcCtD
Sumatriptan—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00624	CcSEcCtD
Sumatriptan—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00168	0.019	CbGeAlD
Sumatriptan—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00592	CcSEcCtD
Sumatriptan—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0059	CcSEcCtD
Sumatriptan—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0058	CcSEcCtD
Sumatriptan—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00577	CcSEcCtD
Sumatriptan—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00561	CcSEcCtD
Sumatriptan—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00561	CcSEcCtD
Sumatriptan—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00561	CcSEcCtD
Sumatriptan—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00552	CcSEcCtD
Sumatriptan—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00522	CcSEcCtD
Sumatriptan—HTR1A—brainstem—amyotrophic lateral sclerosis	0.0014	0.0158	CbGeAlD
Sumatriptan—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00518	CcSEcCtD
Sumatriptan—MAOA—embryo—amyotrophic lateral sclerosis	0.00139	0.0158	CbGeAlD
Sumatriptan—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00497	CcSEcCtD
Sumatriptan—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00488	CcSEcCtD
Sumatriptan—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00485	CcSEcCtD
Sumatriptan—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00485	CcSEcCtD
Sumatriptan—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00485	CcSEcCtD
Sumatriptan—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00475	CcSEcCtD
Sumatriptan—MAOA—brainstem—amyotrophic lateral sclerosis	0.00128	0.0144	CbGeAlD
Sumatriptan—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00472	CcSEcCtD
Sumatriptan—DRD2—brainstem—amyotrophic lateral sclerosis	0.00126	0.0143	CbGeAlD
Sumatriptan—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00466	CcSEcCtD
Sumatriptan—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00465	CcSEcCtD
Sumatriptan—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00461	CcSEcCtD
Sumatriptan—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00453	CcSEcCtD
Sumatriptan—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00448	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00443	CcSEcCtD
Sumatriptan—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00441	CcSEcCtD
Sumatriptan—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00439	CcSEcCtD
Sumatriptan—Depression—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00431	CcSEcCtD
Sumatriptan—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00426	CcSEcCtD
Sumatriptan—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00424	CcSEcCtD
Sumatriptan—SLCO1A2—medulla oblongata—amyotrophic lateral sclerosis	0.00114	0.0128	CbGeAlD
Sumatriptan—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00415	CcSEcCtD
Sumatriptan—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00412	CcSEcCtD
Sumatriptan—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00408	CcSEcCtD
Sumatriptan—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00406	CcSEcCtD
Sumatriptan—HTR3A—nervous system—amyotrophic lateral sclerosis	0.00108	0.0122	CbGeAlD
Sumatriptan—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.00108	0.0122	CbGeAlD
Sumatriptan—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00395	CcSEcCtD
Sumatriptan—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0039	CcSEcCtD
Sumatriptan—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00388	CcSEcCtD
Sumatriptan—HTR3A—central nervous system—amyotrophic lateral sclerosis	0.00104	0.0118	CbGeAlD
Sumatriptan—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00386	CcSEcCtD
Sumatriptan—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00386	CcSEcCtD
Sumatriptan—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00381	CcSEcCtD
Sumatriptan—SLCO1A2—spinal cord—amyotrophic lateral sclerosis	0.00101	0.0115	CbGeAlD
Sumatriptan—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000976	0.00363	CcSEcCtD
Sumatriptan—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000948	0.00352	CcSEcCtD
Sumatriptan—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000944	0.00351	CcSEcCtD
Sumatriptan—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000942	0.0035	CcSEcCtD
Sumatriptan—Chills—Riluzole—amyotrophic lateral sclerosis	0.000938	0.00348	CcSEcCtD
Sumatriptan—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000933	0.00347	CcSEcCtD
Sumatriptan—HTR1B—nervous system—amyotrophic lateral sclerosis	0.000908	0.0103	CbGeAlD
Sumatriptan—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000896	0.00333	CcSEcCtD
Sumatriptan—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000891	0.00331	CcSEcCtD
Sumatriptan—MAOA—medulla oblongata—amyotrophic lateral sclerosis	0.000891	0.0101	CbGeAlD
Sumatriptan—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00088	0.00327	CcSEcCtD
Sumatriptan—HTR1D—nervous system—amyotrophic lateral sclerosis	0.000879	0.00994	CbGeAlD
Sumatriptan—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000874	0.00325	CcSEcCtD
Sumatriptan—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.000874	0.00988	CbGeAlD
Sumatriptan—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.000869	0.00983	CbGeAlD
Sumatriptan—SLCO1A2—nervous system—amyotrophic lateral sclerosis	0.000854	0.00965	CbGeAlD
Sumatriptan—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000852	0.00317	CcSEcCtD
Sumatriptan—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.000846	0.00957	CbGeAlD
Sumatriptan—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000844	0.00314	CcSEcCtD
Sumatriptan—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00312	CcSEcCtD
Sumatriptan—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000836	0.00311	CcSEcCtD
Sumatriptan—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000831	0.00309	CcSEcCtD
Sumatriptan—HTR3A—brain—amyotrophic lateral sclerosis	0.000827	0.00935	CbGeAlD
Sumatriptan—SLCO1A2—central nervous system—amyotrophic lateral sclerosis	0.000822	0.00929	CbGeAlD
Sumatriptan—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00082	0.00305	CcSEcCtD
Sumatriptan—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000817	0.00304	CcSEcCtD
Sumatriptan—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000816	0.00303	CcSEcCtD
Sumatriptan—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000804	0.00299	CcSEcCtD
Sumatriptan—SLCO1A2—cerebellum—amyotrophic lateral sclerosis	0.000804	0.00908	CbGeAlD
Sumatriptan—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000799	0.00297	CcSEcCtD
Sumatriptan—MAOA—spinal cord—amyotrophic lateral sclerosis	0.000794	0.00898	CbGeAlD
Sumatriptan—Cough—Riluzole—amyotrophic lateral sclerosis	0.000794	0.00295	CcSEcCtD
Sumatriptan—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000788	0.00293	CcSEcCtD
Sumatriptan—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000785	0.00292	CcSEcCtD
Sumatriptan—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000774	0.00288	CcSEcCtD
Sumatriptan—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000774	0.00288	CcSEcCtD
Sumatriptan—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000774	0.00288	CcSEcCtD
Sumatriptan—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000772	0.00873	CbGeAlD
Sumatriptan—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000772	0.00287	CcSEcCtD
Sumatriptan—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000765	0.00284	CcSEcCtD
Sumatriptan—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000757	0.00281	CcSEcCtD
Sumatriptan—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000749	0.00278	CcSEcCtD
Sumatriptan—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000742	0.00276	CcSEcCtD
Sumatriptan—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000742	0.00276	CcSEcCtD
Sumatriptan—Infection—Riluzole—amyotrophic lateral sclerosis	0.000737	0.00274	CcSEcCtD
Sumatriptan—HTR1A—nervous system—amyotrophic lateral sclerosis	0.000732	0.00828	CbGeAlD
Sumatriptan—Shock—Riluzole—amyotrophic lateral sclerosis	0.00073	0.00271	CcSEcCtD
Sumatriptan—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000728	0.0027	CcSEcCtD
Sumatriptan—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000727	0.0027	CcSEcCtD
Sumatriptan—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000725	0.00269	CcSEcCtD
Sumatriptan—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000721	0.00268	CcSEcCtD
Sumatriptan—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000718	0.00267	CcSEcCtD
Sumatriptan—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.000705	0.00797	CbGeAlD
Sumatriptan—HTR1B—brain—amyotrophic lateral sclerosis	0.000694	0.00784	CbGeAlD
Sumatriptan—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000694	0.00258	CcSEcCtD
Sumatriptan—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.000689	0.00779	CbGeAlD
Sumatriptan—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000688	0.00778	CbGeAlD
Sumatriptan—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000676	0.00251	CcSEcCtD
Sumatriptan—HTR1D—brain—amyotrophic lateral sclerosis	0.000672	0.00759	CbGeAlD
Sumatriptan—MAOA—nervous system—amyotrophic lateral sclerosis	0.000669	0.00757	CbGeAlD
Sumatriptan—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000667	0.00248	CcSEcCtD
Sumatriptan—DRD2—nervous system—amyotrophic lateral sclerosis	0.000662	0.00748	CbGeAlD
Sumatriptan—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000662	0.00246	CcSEcCtD
Sumatriptan—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00066	0.00245	CcSEcCtD
Sumatriptan—SLCO1A2—brain—amyotrophic lateral sclerosis	0.000653	0.00738	CbGeAlD
Sumatriptan—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000645	0.0024	CcSEcCtD
Sumatriptan—MAOA—central nervous system—amyotrophic lateral sclerosis	0.000644	0.00728	CbGeAlD
Sumatriptan—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000641	0.00238	CcSEcCtD
Sumatriptan—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00064	0.00238	CcSEcCtD
Sumatriptan—DRD2—central nervous system—amyotrophic lateral sclerosis	0.000637	0.0072	CbGeAlD
Sumatriptan—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000635	0.00236	CcSEcCtD
Sumatriptan—Pain—Riluzole—amyotrophic lateral sclerosis	0.000635	0.00236	CcSEcCtD
Sumatriptan—MAOA—cerebellum—amyotrophic lateral sclerosis	0.00063	0.00712	CbGeAlD
Sumatriptan—DRD2—cerebellum—amyotrophic lateral sclerosis	0.000623	0.00704	CbGeAlD
Sumatriptan—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000612	0.00227	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000607	0.00226	CcSEcCtD
Sumatriptan—ABCB1—embryo—amyotrophic lateral sclerosis	0.000596	0.00674	CbGeAlD
Sumatriptan—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00059	0.00219	CcSEcCtD
Sumatriptan—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000587	0.00218	CcSEcCtD
Sumatriptan—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000587	0.00218	CcSEcCtD
Sumatriptan—HTR1A—brain—amyotrophic lateral sclerosis	0.00056	0.00633	CbGeAlD
Sumatriptan—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000547	0.00203	CcSEcCtD
Sumatriptan—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000546	0.00617	CbGeAlD
Sumatriptan—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000533	0.00198	CcSEcCtD
Sumatriptan—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000525	0.00195	CcSEcCtD
Sumatriptan—MAOA—brain—amyotrophic lateral sclerosis	0.000511	0.00578	CbGeAlD
Sumatriptan—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000508	0.00189	CcSEcCtD
Sumatriptan—DRD2—brain—amyotrophic lateral sclerosis	0.000506	0.00572	CbGeAlD
Sumatriptan—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000491	0.00182	CcSEcCtD
Sumatriptan—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000472	0.00175	CcSEcCtD
Sumatriptan—Rash—Riluzole—amyotrophic lateral sclerosis	0.000468	0.00174	CcSEcCtD
Sumatriptan—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000468	0.00174	CcSEcCtD
Sumatriptan—Headache—Riluzole—amyotrophic lateral sclerosis	0.000465	0.00173	CcSEcCtD
Sumatriptan—ABCG2—brain—amyotrophic lateral sclerosis	0.000443	0.00501	CbGeAlD
Sumatriptan—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000441	0.00164	CcSEcCtD
Sumatriptan—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000381	0.0043	CbGeAlD
Sumatriptan—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000339	0.00384	CbGeAlD
Sumatriptan—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000286	0.00323	CbGeAlD
Sumatriptan—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000275	0.00311	CbGeAlD
Sumatriptan—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000269	0.00304	CbGeAlD
Sumatriptan—ABCB1—brain—amyotrophic lateral sclerosis	0.000219	0.00247	CbGeAlD
Sumatriptan—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	6.49e-05	0.00341	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	6.47e-05	0.0034	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	6.47e-05	0.0034	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	5.92e-05	0.00311	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	5.84e-05	0.00307	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	5.84e-05	0.00307	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.75e-05	0.00302	CbGpPWpGaD
Sumatriptan—HTR3A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	5.7e-05	0.00299	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.7e-05	0.00299	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	5.68e-05	0.00298	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	5.46e-05	0.00287	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	5.46e-05	0.00287	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	5.3e-05	0.00278	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	5.23e-05	0.00274	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.09e-05	0.00267	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—TPK1—amyotrophic lateral sclerosis	5.06e-05	0.00266	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—VAPB—amyotrophic lateral sclerosis	5.06e-05	0.00266	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	5e-05	0.00262	CbGpPWpGaD
Sumatriptan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	4.96e-05	0.0026	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	4.93e-05	0.00259	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.87e-05	0.00256	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.84e-05	0.00254	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.84e-05	0.00254	CbGpPWpGaD
Sumatriptan—HTR1D—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	4.76e-05	0.0025	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.67e-05	0.00245	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.67e-05	0.00245	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	4.66e-05	0.00245	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.64e-05	0.00244	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—VAPA—amyotrophic lateral sclerosis	4.63e-05	0.00243	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	4.62e-05	0.00243	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	4.54e-05	0.00239	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.51e-05	0.00237	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—C3—amyotrophic lateral sclerosis	4.51e-05	0.00237	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	4.41e-05	0.00231	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	4.37e-05	0.00229	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.36e-05	0.00229	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	4.33e-05	0.00227	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	4.33e-05	0.00227	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	4.33e-05	0.00227	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.32e-05	0.00227	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.3e-05	0.00226	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.27e-05	0.00224	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	4.15e-05	0.00218	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.14e-05	0.00217	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.14e-05	0.00217	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	4.13e-05	0.00217	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—FIG4—amyotrophic lateral sclerosis	4.05e-05	0.00212	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.97e-05	0.00209	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.96e-05	0.00208	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—DAO—amyotrophic lateral sclerosis	3.95e-05	0.00207	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	3.89e-05	0.00204	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.83e-05	0.00201	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.83e-05	0.00201	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	3.79e-05	0.00199	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	3.78e-05	0.00199	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.73e-05	0.00196	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	3.73e-05	0.00196	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	3.71e-05	0.00195	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.69e-05	0.00194	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—VCP—amyotrophic lateral sclerosis	3.68e-05	0.00193	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.68e-05	0.00193	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—DAO—amyotrophic lateral sclerosis	3.66e-05	0.00192	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	3.66e-05	0.00192	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	3.57e-05	0.00187	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	3.55e-05	0.00187	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	3.46e-05	0.00182	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	3.43e-05	0.0018	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.42e-05	0.00179	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	3.39e-05	0.00178	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	3.38e-05	0.00177	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	3.32e-05	0.00174	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	3.2e-05	0.00168	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	3.17e-05	0.00166	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	3.13e-05	0.00164	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	3.13e-05	0.00164	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	3.12e-05	0.00164	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.99e-05	0.00157	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	2.92e-05	0.00153	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	2.91e-05	0.00153	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.88e-05	0.00151	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	2.82e-05	0.00148	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.82e-05	0.00148	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	2.78e-05	0.00146	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PLB1—amyotrophic lateral sclerosis	2.77e-05	0.00146	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSR—amyotrophic lateral sclerosis	2.76e-05	0.00145	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.73e-05	0.00144	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.7e-05	0.00142	CbGpPWpGaD
Sumatriptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.68e-05	0.00141	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.64e-05	0.00139	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.62e-05	0.00137	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.59e-05	0.00136	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.58e-05	0.00135	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.56e-05	0.00134	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSR—amyotrophic lateral sclerosis	2.56e-05	0.00134	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.55e-05	0.00134	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	2.53e-05	0.00133	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.52e-05	0.00132	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.48e-05	0.0013	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	2.48e-05	0.0013	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	2.48e-05	0.0013	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	2.45e-05	0.00128	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.44e-05	0.00128	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.43e-05	0.00128	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.37e-05	0.00124	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	2.36e-05	0.00124	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.36e-05	0.00124	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.34e-05	0.00123	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.34e-05	0.00123	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.32e-05	0.00122	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.31e-05	0.00122	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.31e-05	0.00121	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.28e-05	0.0012	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.27e-05	0.00119	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.23e-05	0.00117	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	2.22e-05	0.00117	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	2.19e-05	0.00115	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.15e-05	0.00113	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.15e-05	0.00113	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.15e-05	0.00113	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.14e-05	0.00112	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CHAT—amyotrophic lateral sclerosis	2.1e-05	0.0011	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.07e-05	0.00109	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.07e-05	0.00109	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.07e-05	0.00109	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.03e-05	0.00106	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.02e-05	0.00106	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2e-05	0.00105	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.99e-05	0.00104	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.98e-05	0.00104	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.97e-05	0.00104	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.96e-05	0.00103	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.94e-05	0.00102	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.92e-05	0.00101	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	1.89e-05	0.000992	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.87e-05	0.000982	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.85e-05	0.000973	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.85e-05	0.00097	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.8e-05	0.000943	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.77e-05	0.000929	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.76e-05	0.000923	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.75e-05	0.000921	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.73e-05	0.000909	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.7e-05	0.000893	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.69e-05	0.000888	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.67e-05	0.000879	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.65e-05	0.000864	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.64e-05	0.000861	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.63e-05	0.000856	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.63e-05	0.000854	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.6e-05	0.000838	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.55e-05	0.000812	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.54e-05	0.00081	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.51e-05	0.000793	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.49e-05	0.000784	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.49e-05	0.000784	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.48e-05	0.000777	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.45e-05	0.000763	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.45e-05	0.000761	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.42e-05	0.000745	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.38e-05	0.000723	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.37e-05	0.000718	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.35e-05	0.000709	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.35e-05	0.000708	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	1.34e-05	0.000705	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.33e-05	0.000697	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.31e-05	0.000689	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.29e-05	0.000678	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.28e-05	0.000673	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.27e-05	0.000668	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.26e-05	0.000664	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.25e-05	0.000656	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.23e-05	0.000645	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.22e-05	0.00064	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.22e-05	0.000638	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.21e-05	0.000637	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.2e-05	0.000632	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.18e-05	0.000621	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.15e-05	0.000601	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.13e-05	0.000593	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.12e-05	0.000588	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.1e-05	0.00058	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.1e-05	0.000576	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.07e-05	0.00056	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.05e-05	0.000552	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.05e-05	0.000552	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.04e-05	0.000547	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.04e-05	0.000545	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.03e-05	0.000541	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.03e-05	0.000539	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.89e-06	0.000519	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.71e-06	0.00051	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.69e-06	0.000509	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.69e-06	0.000509	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.65e-06	0.000507	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.63e-06	0.000505	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.58e-06	0.000503	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	9.22e-06	0.000484	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.17e-06	0.000481	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.01e-06	0.000473	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.87e-06	0.000466	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.74e-06	0.000459	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	8.65e-06	0.000454	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.56e-06	0.000449	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—APOE—amyotrophic lateral sclerosis	8.54e-06	0.000448	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.45e-06	0.000444	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.14e-06	0.000427	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.1e-06	0.000425	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.05e-06	0.000423	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.97e-06	0.000418	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	7.88e-06	0.000414	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.85e-06	0.000412	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.65e-06	0.000402	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.38e-06	0.000387	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	7.3e-06	0.000383	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.89e-06	0.000362	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.87e-06	0.000361	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.73e-06	0.000353	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.59e-06	0.000346	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.52e-06	0.000342	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.48e-06	0.00034	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.32e-06	0.000332	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.07e-06	0.000319	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.85e-06	0.000307	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.73e-06	0.000301	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.4e-06	0.000284	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.33e-06	0.00028	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.22e-06	0.000274	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.19e-06	0.000273	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.18e-06	0.000272	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.07e-06	0.000266	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.02e-06	0.000263	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5e-06	0.000263	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.89e-06	0.000257	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.8e-06	0.000252	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.79e-06	0.000252	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.4e-06	0.000231	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.39e-06	0.000231	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.3e-06	0.000226	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.95e-06	0.000207	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.86e-06	0.000203	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.65e-06	0.000192	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.39e-06	0.000178	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.32e-06	0.000174	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.28e-06	0.000172	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.25e-06	0.000171	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.2e-06	0.000168	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.88e-06	0.000151	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.7e-06	0.000142	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.48e-06	0.00013	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.17e-06	0.000114	CbGpPWpGaD
